ISSN: 1307-5888 | E-ISSN: 2757-7392 | Contact
Volume: 4 Issue: 3 Year: 2023
Copyright Transfer Form Author Contribution Form ICMJE COI Form
Submit an Article

Volume: 4 Issue: 3 - 2023

Front Matter

1. Front Matter
Full Text PDF

Editorial

2. The heated debate over NAFLD renaming: An ongoing saga
Yusuf Yilmaz
DOI: 10.14744/hf.2023.2023.0044 Pages : 89-91
Full Text PDF

Research Articles

3. The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort
Serkan Yaras, Mehmet Demir, Sezgin Barutcu, Abdullah Emre Yıldırım, Selim Gurel, Enver Ucbilek, Ilkce Akgun Kurtulmus, Meral Akdogan Kayhan, Sezgin Vatansever, Haydar Adanir, Nilay Danis, Serkan Duman, Ilker Turan, Derya Ari, Sukran Kose, Huseyin Alkim, Muhsin Murat Harputluoglu, Feyza Dilber, Murat Akyildiz, Arif Mansur Cosar, Serdar Durak, Goktug Sirin, Ayse Kefeli, Hale Gokcan, Ufuk Avcioglu, Talat Ayyildiz, Orhan Sezgin, Mesut Akarsu, Dinc Dincer, Fatih Guzelbulut, Fulya Gunsar, Ulus Salih Akarca, Ramazan Idilman
DOI: 10.14744/hf.2023.2023.0001 Pages : 92-96
Abstract Full Text PDF
4. Incidental combined hepatocellular-cholangiocarcinoma in liver transplant patients: Does it have a worse prognosis?
Ender Anilir, Alihan Oral, Fatih Turker, Tolga Sahin, Yildiray Yuzer, Yaman Tokat
DOI: 10.14744/hf.2022.2022.0037 Pages : 97-102
Abstract Full Text PDF
5. Is the Y90-Radioembolization treatment effective on the intermediate-advanced stage of Hepatocellular Carcinoma and What is the Albumin-Bilirubin score's prediction factor for survival?
Sami Evirgen, Bilger Cavus, Suut Gokturk, Raim Iliaz, Zeynep Gozde Ozkan, Bulent Baran, Aslı Ciftcibası Ormeci, Ozlem Mutluay Soyer, Cetin Karaca, Kadir Demir, Selman Fatih Besisik, Arzu Poyanli, Filiz Akyuz, Sabahattin Kaymakoglu
DOI: 10.14744/hf.2022.2022.0036 Pages : 103-107
Abstract Full Text PDF
6. Bioinformatic Analysis of Genetic Changes CLOCK, BMAL1, CRY1, CRY2, PER1, PER2, PER3 and NPAS2 Proteins in HCC Patients
Durmuş Ayan, Çagatay Ak
DOI: 10.14744/hf.2023.2023.0009 Pages : 108-117
Abstract Full Text PDF
7. A new method for predicting alcohol relapse in patients undergoing liver transplantation for alcohol-related liver failure: Barratt scale
Veysel Umman, Ebubekir Korucuk, Recep Temel, Ozen Onen Sertoz, Fulya Gunsar, Alper Uguz, Murat Zeytunlu, Sukru Emre
DOI: 10.14744/hf.2023.2023.0048 Pages : 118-122
Abstract Full Text PDF
8. Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
Ayşe Sakalli Kani, Ahmet Ozercan, Haluk Tarik Kani, Fatih Eren, Kemal Sayar, Yusuf Yilmaz
DOI: 10.14744/hf.2023.2023.0034 Pages : 123-128
Abstract Full Text PDF
9. Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study
Gupse Adali, Nermin Mutlu Bilgic, Ahmet Emre Kalaman, Oguzhan Ozturk, Kamil Ozdil
DOI: 10.14744/hf.2023.2023.0032 Pages : 129-134
Abstract Full Text PDF
10. Protective/preventive effects of quercetin against cyclophosphamide-induced hepatic inflammation, apoptosis and fibrosis in rats
Sibel Turedi
DOI: 10.14744/hf.2023.2023.0026 Pages : 135-141
Abstract Full Text PDF

Case Report

11. Recurrent Early Onset Severe Obstetric Cholestasis in a Patient With Two Variants in the ABCB4 Gene: A Case Report
Mohammad Fawad Khattak, Sam Thomson
DOI: 10.14744/hf.2023.2023.0008 Pages : 142-144
Abstract Full Text PDF

Review Article

12. Practice patterns and considerations in liver transplantation from living donors with high BMI: A review
Carl Samaha, Hadi Chaaban, Cem Simsek, Nilay Danis, Jessica S. Lin, Ahmet Gurakar
DOI: 10.14744/hf.2023.2023.0030 Pages : 145-149
Abstract Full Text PDF

Letter to the Editor

13. Should dermatologists care about hepatic fibrosis and steatosis? Psoriasis first, hidradenitis suppurativa second
Enzo Emanuele, Piercarlo Minoretti
DOI: 10.14744/hf.2023.2023.0029 Pages : 150-151
Full Text PDF